{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:37:45Z","timestamp":1774525065224,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1475-2875-13-439","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T05:59:47Z","timestamp":1416463187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in C\u00f4te d'Ivoire"],"prefix":"10.1186","volume":"13","author":[{"given":"Offianan A","family":"Toure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge B","family":"Assi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiacoh L","family":"N\u2019Guessan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gbessi E","family":"Adji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristide B","family":"Ako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie J","family":"Brou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie F","family":"Ehouman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laeticia A","family":"Gnamien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u2019Lanhoro AA","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baba","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Beourou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issiaka","family":"Bassinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adama","family":"Soumahoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Kadjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mea A","family":"Tano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,19]]},"reference":[{"key":"3604_CR1","volume-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Guidelines for the treatment of malaria. 2010, Geneva: WHO Press, 2","edition":"2"},{"key":"3604_CR2","volume-title":"Methods for surveillance of antimalarial drug efficacy","author":"WHO","year":"2009","unstructured":"WHO: Methods for surveillance of antimalarial drug efficacy. 2009, World Health Organization: Geneva, [\n                    http:\/\/whqlibdoc.who.int\/publications\/2009\/9789241597531_eng.pdf\n                    \n                  ]"},{"key":"3604_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrmicro2385","volume":"8","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Yeung S, White L, Nguon C, Day NP, Socheat D, Von Seidlein L: Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 2010, 8: 272-280.","journal-title":"Nat Rev Microbiol"},{"key":"3604_CR4","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","volume":"379","author":"AP Phyo","year":"2012","unstructured":"Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F: Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012, 379: 1960-1966. 10.1016\/S0140-6736(12)60484-X.","journal-title":"Lancet"},{"key":"3604_CR5","first-page":"608","volume":"15","author":"B Faye","year":"2010","unstructured":"Faye B, Offianan AT, Ndiaye JL, Tine RC, Tour\u00e9 W, Djoman K, Sylla K, Ndiaye PS, Penali L, Gaye O: Efficacy and tolerability of artesunate- amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast. Trop Med Int Health. 2010, 15: 608-613.","journal-title":"Trop Med Int Health"},{"key":"3604_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1475-2875-8-148","volume":"8","author":"OA Toure","year":"2009","unstructured":"Toure OA, Penali LK, Yapi JD, Ako BA, Toure W, Djerea K, Gomez GO, Makaila OA: Comparative, randomized clinical trial of artemisinin\/naphtoquine twice daily one day versus artemether\/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in C\u00f4te d\u2019Ivoire. Malar J. 2009, 8: 148-10.1186\/1475-2875-8-148.","journal-title":"Malar J"},{"key":"3604_CR7","volume-title":"Malaria policies and strategies in C\u00f4te d\u2019Ivoire","author":"National Malaria Control Programme","year":"2008","unstructured":"National Malaria Control Programme: Malaria policies and strategies in C\u00f4te d\u2019Ivoire. 2008, Abidjan: NMCP"},{"key":"3604_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/13648470903264931","volume":"16","author":"S Granado","year":"2009","unstructured":"Granado S, Obrist B, Manderson L, Tanner M: The moment of sale: treating malaria in Abidjan, C\u00f4te d\u2019Ivoire. Anthropol Med. 2009, 16: 319-331. 10.1080\/13648470903264931.","journal-title":"Anthropol Med"},{"key":"3604_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1475-2875-7-95","volume":"7","author":"M Tipke","year":"2008","unstructured":"Tipke M, Diallo S, Coulibaly B, St\u00f6rzinger D, Hoppe-Tichy T, Sie A, Olaf M\u00fcller O: Substandard anti-malarial drugs in Burkina Faso. Malar J. 2008, 7: 95-10.1186\/1475-2875-7-95.","journal-title":"Malar J"},{"key":"3604_CR10","first-page":"7","volume":"24","author":"E Aka","year":"2005","unstructured":"Aka E, Legris C, Tanimoto T, Matsushita R, Kimura K: Counterfeit medicine detection by authenticity investigation: a pilot study in the street market of C\u00f4te d\u2019Ivoire. Jpn J Soc Pharm. 2005, 24: 7-16.","journal-title":"Jpn J Soc Pharm"},{"key":"3604_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, M\u00e9nard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, M\u00e9nard D: A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014, 505: 50-55.","journal-title":"Nature"},{"key":"3604_CR12","first-page":"50","volume-title":"Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria","author":"WHO","year":"2003","unstructured":"WHO: Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. 2003, World Health Organization, Geneva: WHO\/HTM\/ RBM, 50-"},{"key":"3604_CR13","doi-asserted-by":"publisher","first-page":"e2390","DOI":"10.1371\/journal.pone.0002390","volume":"3","author":"A Yeka","year":"2008","unstructured":"Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, Staedke SG, Rosenthal PJ, Wabwire-Mangen F, Bukirwa H: Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS One. 2008, 3: e2390-10.1371\/journal.pone.0002390.","journal-title":"PLoS One"},{"key":"3604_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0140-6736(07)60236-0","volume":"369","author":"I Zongo","year":"2007","unstructured":"Zongo I, Dorsey G, Rouamba N, Tinto H, Dokomajilar C, Guiguemde RT, Rosenthal PJ, Ouedraogo JB: Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Lancet. 2007, 369: 491-498. 10.1016\/S0140-6736(07)60236-0. Erratum in: Lancet. 2007, 369:826","journal-title":"Lancet"},{"key":"3604_CR15","volume-title":"Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations: 29\u201331 May 2007","author":"MMV\/WHO","year":"2008","unstructured":"MMV\/WHO: Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations: 29\u201331 May 2007. 2008, Amsterdam, The Netherlands: WHO, [\n                    http:\/\/whqlibdoc.who.int\/publications\/2008\/ 9789241596305_eng.pdf\n                    \n                  ]"},{"key":"3604_CR16","volume-title":"World malaria report 2013","author":"WHO","year":"2013","unstructured":"WHO: World malaria report 2013. 2013, Geneva: World Health Organization"},{"key":"3604_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-467. 10.1056\/NEJMoa0808859.","journal-title":"N Engl J Med"},{"key":"3604_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1056\/NEJMc0900231","volume":"361","author":"H Noedl","year":"2009","unstructured":"Noedl H, Socheat D, Satimai W: Artemisinin-resistant malaria in Asia. N Engl J Med. 2009, 361: 540-541. 10.1056\/NEJMc0900231.","journal-title":"N Engl J Med"},{"key":"3604_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1365-3156.2010.02701.x","volume":"16","author":"AT Offianan","year":"2011","unstructured":"Offianan AT, Menan GK, Yapi JD, Ako AAB, Khali D, Gomez OG, Louis KP: Artesunate\/mefloquine paediatric formulation vs. artemether\/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua koute, C\u00f4te d\u2019Ivoire. Trop Med Int Health. 2011, 16: 290-297. 10.1111\/j.1365-3156.2010.02701.x.","journal-title":"Trop Med Int Health"},{"key":"3604_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/1475-2875-11-433","volume":"11","author":"B Faye","year":"2012","unstructured":"Faye B, Ku\u00e9t\u00e9 T, Kiki-Barro CP, Tine RC, Nkoa T, Ndiaye JL, Kakpo CA, Khadime S, Menan HEI, Gaye O, Faye O, Same-Ekobo A, Kone M: Multicentre study evaluating the non-inferiority ofthe new paediatric formulation of artesunate\/amodiaquine versus artemether\/lumefantrine forthe management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and Senegal. Malar J. 2012, 11: 433-10.1186\/1475-2875-11-433.","journal-title":"Malar J"},{"key":"3604_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/OAJCT.S24687","volume":"3","author":"A Toure Offianan","year":"2011","unstructured":"Toure Offianan A, Assi SB, Aristide MA C, N\u2019guessan LT, Ako AA, Kadjo FK, San MK, Penali LK: Assessment of the efficacy of first-line antimalarial drugs after 5 years of deployment by the National Malaria Control Programme in C\u00f4te d\u2019Ivoire. Open Access Journal of Clinical Trials. 2011, 3: 67-76.","journal-title":"Open Access Journal of Clinical Trials"},{"key":"3604_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/1475-2875-11-174","volume":"11","author":"E Espie","year":"2012","unstructured":"Espie E, Lima A, Atua B, Dhorda M, Fl\u00e9vaud L, Sompwe EM, Palma Urrutia PP, Guerin PJ: Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial. Malar J. 2012, 11: 174-10.1186\/1475-2875-11-174.","journal-title":"Malar J"},{"key":"3604_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1475-2875-12-251","volume":"12","author":"B Schramm","year":"2013","unstructured":"Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R, Pinoges L, Dhorda M, Boum Y, Sundaygar T, Zolia YM, Jones JJ, Comte E, Houz\u00e9 P, Jullien V, Carn G, Kiechel JR, Ashley EA, Gu\u00e9rin PJ: Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59\u00a0months in Nimba County Liberia: an open-label randomized non-inferiority trial. Malar J. 2013, 12: 251-10.1186\/1475-2875-12-251.","journal-title":"Malar J"},{"key":"3604_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1475-2875-12-53","volume":"12","author":"M Ndounga","year":"2013","unstructured":"Ndounga M, Mayengue PI, Casimiro PN, Loumouamou D, Basco LK, Ntoumi F, Brasseur P: Artesunate-amodiaquine efficacy in Congolese children with acute uncomplicated falciparum malaria in Brazzaville. Malar J. 2013, 12: 53-10.1186\/1475-2875-12-53.","journal-title":"Malar J"},{"key":"3604_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1475-2875-10-237","volume":"10","author":"JL Ndiaye","year":"2011","unstructured":"Ndiaye JL, Faye B, Gueye A, Tine R, Ndiaye D, Tchania C, Ndiaye I, Barry A, Ciss\u00e9 B, Lameyre V, Gaye O: Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Malar J. 2011, 10: 237-10.1186\/1475-2875-10-237.","journal-title":"Malar J"},{"key":"3604_CR26","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1086\/650301","volume":"201","author":"K Stepniewska","year":"2010","unstructured":"Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, De Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ: In vivo parasitological measures of artemisinin susceptibility. J Infect Dis. 2010, 201: 570-579. 10.1086\/650301.","journal-title":"J Infect Dis"},{"key":"3604_CR27","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/1475-2875-11-364","volume":"11","author":"K Kayentao","year":"2012","unstructured":"Kayentao K, Doumbo OK, P\u00e9nali LK, Offianan AT, Bhatt KM, Kimani J, Tshefu AK, Kokolomami JH, Ramharter M, de Salazar PM, Tiono AB, Ou\u00e9draogo A, Bustos MD, Quicho F, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L: Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial. Malar J. 2012, 11: 364-10.1186\/1475-2875-11-364.","journal-title":"Malar J"},{"key":"3604_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/1475-2875-10-339","volume":"10","author":"JA Flegg","year":"2011","unstructured":"Flegg JA, Guerin PJ, White NJ, Stepniewska K: Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J. 2011, 10: 339-10.1186\/1475-2875-10-339.","journal-title":"Malar J"},{"key":"3604_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/1475-2875-12-250","volume":"12","author":"B Schramm","year":"2013","unstructured":"Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R, Pinoges L, Sundaygar T, Zolia YM, Jones J, Comte E, Bruneel A, Branger M, Jullien V, Carn G, Kiechel JR, Ashley EA, Gu\u00e9rin PJ: Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County. Liberia. Malar J. 2013, 12: 250-10.1186\/1475-2875-12-250.","journal-title":"Liberia. Malar J"},{"key":"3604_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4269\/ajtmh.2012.11-0047","volume":"86","author":"A Ratsimbasoa","year":"2012","unstructured":"Ratsimbasoa A, Ravony H, Vonimpaisomihanta JA, Raherinjafy R, Jahevitra M, Rapelanoro R, Rakotomanga Jde D, Malvy D, Millet P, M\u00e9nard D: Compliance, safety, and effectiveness of fixed-dose artesunateamodiaquine for presumptive treatment of non severe malaria in the context of home management of malaria in Madagascar. Am J Trop Med Hyg. 2012, 86: 203-210. 10.4269\/ajtmh.2012.11-0047.","journal-title":"Am J Trop Med Hyg"},{"key":"3604_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1475-2875-10-127","volume":"10","author":"CK Ahorlu","year":"2011","unstructured":"Ahorlu CK, Koram KA, Seake-Kwawu A, Weiss MG: Two-year evaluation of Intermittent Preventive Treatment for Children (IPTc) combined with timely home treatment for malaria control in Ghana. Malar J. 2011, 10: 127-10.1186\/1475-2875-10-127.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-13-439.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T21:41:02Z","timestamp":1548193262000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-13-439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3604"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-13-439","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,19]]},"assertion":[{"value":"26 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"439"}}